Zantac’s maker kept quiet about cancer risks for 40 years
> Intense public scrutiny on Zantac started in 2019, when an online pharmacy found high levels of a likely carcinogen in the drug and its generics.And the linked article says:> Valisure discovered the link of Zantac and its generics to the carcinogen NDMA during its routine testing of every batch of every medication, and first notified the FDA of its initial findings in June of 2019.  On September 13th, Valisure filed a detailed petition with the Food and Drug Administration asking the agency to recall all products containing ranitidine.How in the world is it profitable for an online pharmacy to do this? It's great, but honestly who would pay extra to an online pharmacy to do this testing? Would most people even believe an online pharmacy that said that they did such testing? I'd love to know how they survive.